Mesoblast Says Most Children Survive After Early Use Of FDA-Approved Cell Therapy For Organ Transplant Related Complication - Mesoblast (NASDAQ:MESO)
Exelixis, Citigroup And Other Big Stocks Moving Lower In Monday's Pre-Market Session - American Express (NYSE:AXP), Bread Finl Hldgs (NYSE:BFH)